Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Blood Advances|October 21, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematologyWilliam A Wood, Peter Marks, Robert M Plovnick, et al.
European Heart Journal|April 13, 2021
A call to action for new global approaches to cardiovascular disease drug solutionsGemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
Circulation|April 20, 2021
A Call to Action for New Global Approaches to Cardiovascular Disease Drug SolutionsGemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disordersDiane Nugent, Suchitra S Acharya, Kimberly J Baumann, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.
Mbio|February 14, 2023
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020Shuting Zhang, Peijun Ma, Marek Orzechowski, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Pageof 9